Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormonal contraception and the skin

B Giannotti1, P Carli

  • 1Institute of Dermatology, University of Florence, Italy.

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|July 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Description of a Helicopter-Borne ECPR Team for Remote Refractory Out-of-Hospital Cardiac Arrest.

Prehospital emergency care·2020
Same author

Predicting value of prehospital body temperature for ICU admission of septic shock patients.

Acute medicine·2020
Same author

[Advanced life support in adultsEuropean Resuscitation Council COVID-19 Guidelines].

Notfall & rettungsmedizin·2020
Same author

Utstein recommendation for emergency stroke care.

International journal of stroke : official journal of the International Stroke Society·2020
Same author

Association between hyperoxemia and mortality in patients treated by eCPR after out-of-hospital cardiac arrest.

The American journal of emergency medicine·2019
Same author

Epinephrine administration in non-shockable out-of-hospital cardiac arrest.

The American journal of emergency medicine·2018

Hormonal contraception is valuable in dermatology for treating androgen-dependent skin conditions and preventing pregnancy during teratogenic treatments. This review covers key uses of hormonal contraceptives in dermatological therapy.

Area of Science:

  • Dermatology
  • Endocrinology
  • Pharmacology

Background:

  • Hormonal contraception offers antiandrogenic effects beneficial for treating androgen-dependent dermatological conditions.
  • Certain dermatological treatments, such as retinoids, thalidomide, and methotrexate, carry teratogenic risks, necessitating reliable pregnancy prevention.

Purpose of the Study:

  • To review the primary indications for utilizing hormonal contraception within dermatological therapy.
  • To highlight the dual role of hormonal contraceptives in managing skin diseases and ensuring patient safety.

Main Methods:

  • Literature review of studies on hormonal contraception in dermatology.
  • Analysis of clinical guidelines and therapeutic recommendations.
  • Synthesis of evidence regarding antiandrogenic and contraceptive properties.

Related Experiment Videos

Main Results:

  • Hormonal contraception is effective for conditions like acne vulgaris, hirsutism, and androgenetic alopecia.
  • It serves as a crucial component of risk management for teratogenic dermatologic therapies.
  • Evidence supports the efficacy and safety of specific hormonal agents in dermatological practice.

Conclusions:

  • Hormonal contraception is an essential therapeutic option in dermatology.
  • Its application addresses both disease treatment and reproductive safety concerns.
  • Further research can optimize its use in combination therapies.